StephanieBauerNP

PubMed

• 9 citations
  Phase-1/-2 study of pomalidomide in chronic GvHD
  Iskra Pusic, Michael P. Rettig, John F. DiPersio, Stephanie Bauer, Kyle McFarland, Robert Peter Gale, S.Z. Pavletic> ;Bone Marrow Transplantation. 2016 Apr 1
• 6 citations
  Treatment of chronic myeloid leukemia following imatinib resistance: a nursing guide to second-line treatment options.
  Stephanie Bauer, Edie Romvari> ;Clinical Journal of Oncology Nursing. 2009 Sep 30

Journal Articles

• Tyrosine Kinase Inhibitors for the Treatment of Chronic-Phase Chronic Myeloid Leukemia: Long-Term Patient Care and Management  
  J Adv Pract Oncol, 1/1/2016
• Interpreting Molecular Monitoring Results and International Standardization in Chronic Myleoid Leukemia  
  Journal of Advanced Practitioner in Oncology, 1/1/2012
• Treatment of Chronic Myeloid Leukemia following Imatinib Resistance: a nursing guide to second-line treatment options  
  CJON, 1/1/2009

Abstracts/Posters

• Ruxolitinib As Sparing Agent for Steroid-Dependent Chronic Graft-Versus-Host Disease (cGVHD)
  H. Jean Khoury, Vamsi Kota, M.B;B.S, Martha Arellano, MD, Stephanie L Bauer, ANP, Anand P Jillella, MD, Amelia Langston, MD, Zaid Al-Kadhimi, MD, Zachariah DeFilipp, M..., ASH, 1/1/2015
• Sildenafil (Revatio) Therapy in Chronic Graft VS. Host: Improvement of Pulmonary CGVHD Symptoms
  Bauer S, ASBMT Annual Meetings, 1/1/2009
• Prolonged Engraftment and/or Primary Graft Failure Following Allogeneic Stem Cell Transplant in Patients treated with Dasatinib
  Bauer S, ASH Annual Meetings, 1/1/2006

Lectures

• Topic Chronic Myelogenous Leukemia 
  1/1/2014